Clinical Trials on KRAS G12C Mutant Solid Tumors in Switzerland
Total 119 results
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
PIQUR Therapeutics AGCompletedAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
Glycotope GmbHCompleted
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationNovartis; Schering-PloughUnknownAdvanced Solid TumorsItaly, Switzerland
-
Kantonsspital GraubuendenUnknownUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificSwitzerland
-
AstraZenecaTerminatedSolid TumorsItaly, Switzerland
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingAdvanced Solid TumorsSwitzerland
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Centre Hospitalier Universitaire VaudoisActive, not recruiting
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Maxivax SAActive, not recruiting
-
Centre Hospitalier Universitaire VaudoisTerminatedSolid Tumor, AdultSwitzerland
-
University of ZurichTerminatedCT Perfusion and MRI Perfusion in Solid TumorsSwitzerland
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, Canada, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Glycotope GmbHCompleted
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
CatalYm GmbHRecruitingSolid Tumor, AdultSpain, Germany, Switzerland
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
T3 Pharmaceuticals AGRecruiting
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Switzerland, Latvia, Bulgaria, Lithuania
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
PfizerCompletedSolid TumorsUnited States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersSpain, Switzerland, United Kingdom, United States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Switzerland, Netherlands, Canada